Monique Klaver
About
Monique Klaver is a scholar working on Urology, Rheumatology and Epidemiology.
According to data from OpenAlex, Monique Klaver has authored 21 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Urology, 11 papers in Rheumatology and 8 papers in Epidemiology. Recurrent topics in Monique Klaver's work include Urinary Bladder and Prostate Research (16 papers), Pelvic floor disorders treatments (11 papers) and Urinary Tract Infections Management (7 papers). Monique Klaver is often cited by papers focused on Urinary Bladder and Prostate Research (16 papers), Pelvic floor disorders treatments (11 papers) and Urinary Tract Infections Management (7 papers). Monique Klaver collaborates with scholars based in Netherlands, United Kingdom and Germany. Monique Klaver's co-authors include Philip Van Kerrebroeck, Christopher R. Chapple, Marcus J. Drake, Ted Drogendijk, Matthias Oelke, Zalmaï Hakimi, Mark Speakman, Christopher Hillary, Chris Harding and J.C. Angulo and has published in prestigious journals such as PLoS ONE, European Urology and Urology.
In The Last Decade
Monique Klaver
21 papers receiving 318 citations
Peers
Monique Klaver
Tomas Knutson Sweden
Vibhash Mishra United Kingdom
Eric Chieh‐Lung Chou Taiwan
Jonathan S. Starkman United States
Pedro Arañó Spain
C. Persu Romania
Stanley Flax Canada
Christian P. Schmidbauer Austria
P. J. MEFFAN New Zealand
R. Blair Egerdie United States
Citations per year, relative to Monique Klaver Monique Klaver (= 1×)
peers
Tomas Knutson
Countries citing papers authored by Monique Klaver
Since
Specialization
Citations
This map shows the geographic impact of Monique Klaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monique Klaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monique Klaver more than expected).
Fields of papers citing papers by Monique Klaver
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Monique Klaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monique Klaver. The network helps show where Monique Klaver may publish in the future.
Co-authorship network of co-authors of Monique Klaver
This figure shows the co-authorship network connecting the top 25 collaborators of Monique Klaver. A scholar is included among the top collaborators of Monique Klaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monique Klaver. Monique Klaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Klaver, Monique, Abdul M. Petersen, Jeanne Louw, & Johann F. Görgens. (2024). Economic validation and comparison of microbial tryptophan, erythritol and collagen production in an integrated sugarcane biorefinery. Biochemical Engineering Journal. 212. 109505–109505.
2.
Klaver, Monique, Abdul M. Petersen, & Johann F. Görgens. (2023). Economic comparison of decentralized versus centralized processing of sugarcane to fructooligosaccharides and ethanol. Biofuels Bioproducts and Biorefining. 17(6). 1566–1578.
3.
Klaver, Monique, et al.. (2020). The impact of lifestyle and reproductive factors on the risk of a second new primary cancer in the contralateral breast: a systematic review and meta-analysis. Cancer Causes & Control. 31(5). 403–416.
4.
Cotterill, Nikki, Chris Harding, Christopher Hillary, et al.. (2017). Qualitative Exploration of the Patient Experience of Underactive Bladder. European Urology. 72(3). 402–407.
5.
Drake, Marcus J., et al.. (2017). Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies. PLoS ONE. 12(2). e0170726–e0170726.
6.
Cotterill, Nikki, Chris Harding, Christopher Hillary, et al.. (2016). Qualitative development of a new patient reported outcome measure for underactive bladder. UWE Research Repository (UWE Bristol).
7.
Drake, Marcus J., Karin S. Coyne, Zalmaï Hakimi, et al.. (2015). Responder and health‐related quality of life analyses in men with lower urinary tract symptoms treated with a fixed‐dose combination of solifenacin and tamsulosin oral‐controlled absorption system: results from the NEPTUNE study. British Journal of Urology. 117(1). 165–172.
8.
Mathias, Susan D., Ross D. Crosby, Jameel Nazir, et al.. (2014). Validation of the Patient Perception of Intensity of Urgency Scale in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. Value in Health. 17(8). 823–829.
9.
Drake, Marcus J., Christopher R. Chapple, Matthias Oelke, et al.. (2014). Long-term Safety and Efficacy of Single-tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-label Extension. European Urology. 67(2). 262–270.
10.
Kerrebroeck, Philip Van, François Haab, J.C. Angulo, et al.. (2013). Efficacy and Safety of Solifenacin Plus Tamsulosin OCAS in Men with Voiding and Storage Lower Urinary Tract Symptoms: Results from a Phase 2, Dose-finding Study (SATURN). European Urology. 64(3). 398–407.
11.
Mathias, Susan D., Ross D. Crosby, Monique Klaver, et al.. (2013). The patient perception of intensity of urgency scale (PPIUS): Its validation in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Value in Health. 16(3). A37–A37.
12.
Kerrebroeck, Philip Van, Christopher R. Chapple, Ted Drogendijk, et al.. (2013). Combination Therapy with Solifenacin and Tamsulosin Oral Controlled Absorption System in a Single Tablet for Lower Urinary Tract Symptoms in Men: Efficacy and Safety Results from the Randomised Controlled NEPTUNE Trial. European Urology. 64(6). 1003–1012.
13.
Chapple, Christopher R., Marcus J. Drake, Philip Van Kerrebroeck, et al.. (2013). Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptoms. British Journal of Urology. 113(5). 696–703.
14.
Drake, Marcus J., Monique Klaver, Ted Drogendijk, et al.. (2013). 1089 Quality of life analyses from NEPTUNE, a phase 3 trial of combination therapy with tamsulosin OCAS™ and solifenacin in men with lower urinary tract symptoms. European Urology Supplements. 12(1). e1089–e1090.
15.
Kerrebroeck, P. Van, et al.. (2011). MP-05.03 The Effects of Tamsulosin OCAS™ Plus Solifenacin on Quality of Life (QoL) Parameters in Men with LUTS Associated with BPH Participating in the SATURN Trial. Urology. 78(3). S58–S59.
16.
Haab, F., P. Van Kerrebroeck, Jiří Klečka, et al.. (2011). UP-02.014 Safety of Tamsulosin OCAS™ plus Solifenacin in Men with LUTS Associated with BPH in the SATURN Trial. Urology. 78(3). S264–S265.
17.
Drake, Marcus J., Mark Speakman, P. Van Kerrebroeck, Ted Drogendijk, & Monique Klaver. (2011). MP-05.01 Evaluating the Efficacy and Safety of Fixed-Dose Combinations of Tamsulosin OCAS™ and Solifenacin in Male LUTS with Storage and Voiding Symptoms: An Overview of the NEPTUNE Trial. Urology. 78(3). S58–S58.
18.
Wyndaele, J J, et al.. (2011). MP-05.02 Combination Therapy with Tamsulosin OCAS™ and Solifenacin is more Effective than Solifenacin Monotherapy as a Treatment for Male LUTS Associated with BPH: Results from the SATURN Trial. Urology. 78(3). S58–S58.
19.
Kerrebroeck, P.E.V. Van, et al.. (2011). 327 EFFECTS OF TAMSULOSIN OCAS™ AND SOLIFENACIN ON EFFICACY AND QOL PARAMETERS IN MEN WITH LUTS/BPH IN THE SATURN TRIAL. European Urology Supplements. 10(2). 120–120.
20.
Kerrebroeck, P. Van, et al.. (2010). MP-01.10: Efficacy of tamsulosin OCAS™ plus solifenacin (TOCAS+Soli) in male LUTS: results from a randomized, dose-ranging, phase II trial (SATURN). Urology. 76(3). S12–S13.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Tomas Knutson Breakdown of academic impact, for papers by Vibhash Mishra Breakdown of academic impact, for papers by Eric Chieh‐Lung Chou Breakdown of academic impact, for papers by Jonathan S. Starkman Breakdown of academic impact, for papers by Pedro Arañó Breakdown of academic impact, for papers by C. Persu Breakdown of academic impact, for papers by Stanley Flax Breakdown of academic impact, for papers by Christian P. Schmidbauer Breakdown of academic impact, for papers by P. J. MEFFAN Breakdown of academic impact, for papers by R. Blair Egerdie